All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

Research output: Book/Report › Commissioned report

Cite this

@book{467de3c19c234697a1306fe5fefe8d4e,

title = "All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin{\textregistered}) for Small Cell Lung Carcinoma.",

author = "D. Hughes and D.A. Hughes and \{All Wales Strategy Group.\}, \{[No Value]\}",

year = "2008",

month = jan,

day = "1",

language = "English",

publisher = "Unknown",

edition = "2008",

}

TY - BOOK

T1 - All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

AU - Hughes, D.

AU - Hughes, D.A.

AU - All Wales Strategy Group., [No Value]

PY - 2008/1/1

Y1 - 2008/1/1

UR - http://www.wales.nhs.uk/sites3/Documents/371/FAR%20topotecan%20for%20company.pdf

M3 - Commissioned report

BT - All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

PB - Unknown

ER -